Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities

v3.20.2
Accrued Expenses And Other Current Liabilities
 6 Months Ended
Jun. 30, 2020
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
        Accrued expenses and other current liabilities as of June 30, 2020 and December 31, 2019 consisted of the following: 
  As of
  June 30, 2020 December 31, 2019
Research and development expenses $ 1,899,830    $ 920,901   
Compensation and benefits 1,670,669    1,591,964   
General and administrative 912,943    360,016   
Sales and marketing 212,807    120,056   
Sales returns and allowances 1,144,427    2,284,175   
Medicaid rebates 101,458    118,271   
Lease liability, current 431,543    155,815   
Other 113,981    89,054   
Total accrued expenses and other current liabilities $ 6,487,658    $ 5,640,252   
        
During the first quarter of 2020, the Company and an executive entered into a separation agreement in which the executive resigned his employment at the Company effective June 30, 2020. Following June 30, 2020, the former executive will receive continued payments of his base salary for a total of nine months, which resulted in an accrual of $0.3 million recognized in accrued expenses and other current liabilities on the Company's accompanying condensed consolidated balance sheet as of June 30, 2020 and is shown within the compensation and benefits line above.
Additionally, during the second quarter of 2020, the Company and an executive entered into a separation agreement in which the executive resigned his employment effective April 24, 2020. The former executive serves as an advisor to the Company's Board of Directors and will continue to serve in such role until December 2021 or until terminated by either party upon thirty days' written notice. The former executive will receive $0.8 million in severance, which will be paid over 18 months beginning when his role as advisor to the Board ends. The Company recognized a $0.8 million severance accrual in other long-term liabilities on the Company's accompanying condensed consolidated balance sheet as of June 30, 2020.